[1]纪晓萌, 韩真真, 袁胜利. 直肠癌放射治疗研究进展[J]. 临床医学进展, 2018, 8:59-63. [2]陈善稳, 刘涛, 武颖超, 等. 局部进展期直肠癌新辅助治疗的研究进展[J]. 中华胃肠外科杂志, 2018, 21:710-715. [3]Wang S, Ni B, Zhang Z, et al. Long non-coding RNA DNM3OS promotes tumor progression and EMT in gastric cancer by associating with Snail[J]. Biochem Biophys Res Commun, 2019, 511:57-62. [4]Fang X, Tang Z, Zhang H, et al. Long non-coding RNA DNM3OS/miR-204-5p/HIP1 axis modulates oral cancer cell viability and migration[J]. J Oral Pathol Med, 2020, 49:865-875. [5]Zhang H, Hua Y, Jiang Z, et al. Cancer associated fibroblasts-promoted LncRNA DNM3OS confers radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma[J]. Clin Cancer Res, 2019, 25:1989-2000. [6]Jo P, Azizian A, Salendo J, et al. Changes of microrna levels in plasma of patients with rectal cancer during chemoradiotherapy[J]. Int J Mol Sci, 2017, 18:1140-1152. [7]Lin M, Zhang Z, Gao M, et al. MicroRNA-193a-3p suppresses the colorectal cancer cell proliferation and progression through downregulating the PLAU expression[J]. Cancer Manag Res, 2019, 11:5353-5363. [8]江丹, 张文燕. 预测直肠癌新辅助放化疗敏感性分子标志物的研究进展[J]. 诊断病理学杂志, 2019, 26:381-386. [9]Wang H, Ji X. SMAD6, positively regulated by the DNM3OS-miR-134-5p axis, confers promoting effects to cell proliferation, migration and EMT process in retinoblastoma[J]. Cancer Cell Int, 2020, 20:23-32. [10]Mitra R, Chen X, Greenawalt EJ, et al. Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition[J]. Nat Commun, 2017, 8:1604-1615. [11]张娟, 冯燕, 和水祥. 过表达miR-5195-3p对结直肠癌细胞凋亡的影响[J]. 基础医学与临床, 2019, 39:385-391. [12]Kong L, Wei Q, Hu X, et al. miR-193a-3p promotes radio-resistance of nasopharyngeal cancer cells by targeting SRSF2 gene and hypoxia signaling pathway[J]. Med Sci Monit Basic Res, 2019, 25:53-62. |